A Case of Intense Pulsed Light Aggravated Rosacea Successfully Treated by Abrocitinib

Lan Mao,1 Ling Xiong,1 Yongqiong Deng,2 Xia Xiong1 1Department of Dermatology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People’s Republic of China; 2Department of Dermatology, Chengdu Integrated Traditional Chinese and Western Medicine Hospital, Chengdu, Sichuan, Peo...

Full description

Saved in:
Bibliographic Details
Main Authors: Mao L, Xiong L, Deng Y, Xiong X
Format: Article
Language:English
Published: Dove Medical Press 2025-06-01
Series:Clinical, Cosmetic and Investigational Dermatology
Subjects:
Online Access:https://www.dovepress.com/a-case-of-intense-pulsed-light-aggravated-rosacea-successfully-treated-peer-reviewed-fulltext-article-CCID
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849425253103566848
author Mao L
Xiong L
Deng Y
Xiong X
author_facet Mao L
Xiong L
Deng Y
Xiong X
author_sort Mao L
collection DOAJ
description Lan Mao,1 Ling Xiong,1 Yongqiong Deng,2 Xia Xiong1 1Department of Dermatology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People’s Republic of China; 2Department of Dermatology, Chengdu Integrated Traditional Chinese and Western Medicine Hospital, Chengdu, Sichuan, People’s Republic of ChinaCorrespondence: Xia Xiong, Email xiongxia789@126.com Yongqiong Deng, Email dengyongqiong1@126.comAbstract: Rosacea is a chronic inflammatory skin condition characterized by facial erythema, papules, pustules, telangiectasia, and flushing. Currently, various treatment options are available, but no definitive cure has been established. Phototherapy is primarily effective for treating telangiectatic rosacea because it helps alleviate erythema and telangiectasia. However, it can also pose risks; when applied inappropriately, phototherapy may worsen rosacea symptoms, making the condition more difficult to manage. This case report presents a patient with rosacea who experienced acute exacerbation after intense pulsed light therapy, characterized by persistent erythema, edema, pustules, exudation, and a burning sensation with pain. Subsequent treatment with oral abrocitinib for 12 weeks led to a gradual resolution of the patient’s facial symptoms. Therefore, we hypothesized that the oral JAK-1 inhibitor abrocitinib not only serves as a promising new treatment option for rosacea but also offers therapeutic benefits in cases of inappropriate phototherapy.Keywords: rosacea, intense pulsed light, JAK inhibitor, abrocitinib
format Article
id doaj-art-7ebb34b337a44daa96aa9165d99fcebd
institution Kabale University
issn 1178-7015
language English
publishDate 2025-06-01
publisher Dove Medical Press
record_format Article
series Clinical, Cosmetic and Investigational Dermatology
spelling doaj-art-7ebb34b337a44daa96aa9165d99fcebd2025-08-20T03:29:49ZengDove Medical PressClinical, Cosmetic and Investigational Dermatology1178-70152025-06-01Volume 18Issue 114171421103615A Case of Intense Pulsed Light Aggravated Rosacea Successfully Treated by AbrocitinibMao L0Xiong L1Deng Y2Xiong X3Department of DermatologyDepartment of DermatologyDepartment of DermatologyDepartment of DermatologyLan Mao,1 Ling Xiong,1 Yongqiong Deng,2 Xia Xiong1 1Department of Dermatology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People’s Republic of China; 2Department of Dermatology, Chengdu Integrated Traditional Chinese and Western Medicine Hospital, Chengdu, Sichuan, People’s Republic of ChinaCorrespondence: Xia Xiong, Email xiongxia789@126.com Yongqiong Deng, Email dengyongqiong1@126.comAbstract: Rosacea is a chronic inflammatory skin condition characterized by facial erythema, papules, pustules, telangiectasia, and flushing. Currently, various treatment options are available, but no definitive cure has been established. Phototherapy is primarily effective for treating telangiectatic rosacea because it helps alleviate erythema and telangiectasia. However, it can also pose risks; when applied inappropriately, phototherapy may worsen rosacea symptoms, making the condition more difficult to manage. This case report presents a patient with rosacea who experienced acute exacerbation after intense pulsed light therapy, characterized by persistent erythema, edema, pustules, exudation, and a burning sensation with pain. Subsequent treatment with oral abrocitinib for 12 weeks led to a gradual resolution of the patient’s facial symptoms. Therefore, we hypothesized that the oral JAK-1 inhibitor abrocitinib not only serves as a promising new treatment option for rosacea but also offers therapeutic benefits in cases of inappropriate phototherapy.Keywords: rosacea, intense pulsed light, JAK inhibitor, abrocitinibhttps://www.dovepress.com/a-case-of-intense-pulsed-light-aggravated-rosacea-successfully-treated-peer-reviewed-fulltext-article-CCIDRosaceaIntense Pulsed LightJAK inhibitorAbrocitinib.
spellingShingle Mao L
Xiong L
Deng Y
Xiong X
A Case of Intense Pulsed Light Aggravated Rosacea Successfully Treated by Abrocitinib
Clinical, Cosmetic and Investigational Dermatology
Rosacea
Intense Pulsed Light
JAK inhibitor
Abrocitinib.
title A Case of Intense Pulsed Light Aggravated Rosacea Successfully Treated by Abrocitinib
title_full A Case of Intense Pulsed Light Aggravated Rosacea Successfully Treated by Abrocitinib
title_fullStr A Case of Intense Pulsed Light Aggravated Rosacea Successfully Treated by Abrocitinib
title_full_unstemmed A Case of Intense Pulsed Light Aggravated Rosacea Successfully Treated by Abrocitinib
title_short A Case of Intense Pulsed Light Aggravated Rosacea Successfully Treated by Abrocitinib
title_sort case of intense pulsed light aggravated rosacea successfully treated by abrocitinib
topic Rosacea
Intense Pulsed Light
JAK inhibitor
Abrocitinib.
url https://www.dovepress.com/a-case-of-intense-pulsed-light-aggravated-rosacea-successfully-treated-peer-reviewed-fulltext-article-CCID
work_keys_str_mv AT maol acaseofintensepulsedlightaggravatedrosaceasuccessfullytreatedbyabrocitinib
AT xiongl acaseofintensepulsedlightaggravatedrosaceasuccessfullytreatedbyabrocitinib
AT dengy acaseofintensepulsedlightaggravatedrosaceasuccessfullytreatedbyabrocitinib
AT xiongx acaseofintensepulsedlightaggravatedrosaceasuccessfullytreatedbyabrocitinib
AT maol caseofintensepulsedlightaggravatedrosaceasuccessfullytreatedbyabrocitinib
AT xiongl caseofintensepulsedlightaggravatedrosaceasuccessfullytreatedbyabrocitinib
AT dengy caseofintensepulsedlightaggravatedrosaceasuccessfullytreatedbyabrocitinib
AT xiongx caseofintensepulsedlightaggravatedrosaceasuccessfullytreatedbyabrocitinib